top of page

Uniquity Bio's CEO on exiting stealth mode with $300M in funding from its parent Blackstone to go after TSLP in the I&I space

  • May 28, 2024
  • 1 min read

Brian Lortie describes how Blackstone has launched the company and the multiple advantages this relationship brings, why TSLP, and the road ahead in terms of indications and the timing of future readouts.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page